4428 Live Notices for Germany Human Drugs Tenders
Showing 1 to 20
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
29 Jan 2025
31 Mar 2027Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Of The Social Code Book V With The Active Ingredient Rivaroxaban In The Dosage Form Hkp
Distribution Of Medicines As Of July 1, 2025
Public Tender (Supply Service) Supply Of Vaccines And Medicines Supply Of Vaccines And Medicines, Framework Contract For 2 Years
Distribution Of Medicines As Of July 1, 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Beclometasone/Formoterol (Atc Code According To Who: R03Ak08)
Crm Solution Communications (As Saas)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Dornase Alfa (Atc Code According To Who: R05Cb13)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Dornase Alfa (Atc Code According To Who: R05Cb13)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Dornase Alfa (Atc Code According To Who: R05Cb13)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Dornase Alfa (Atc Code According To Who: R05Cb13)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Dornase Alfa (Atc Code According To Who: R05Cb13)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Dornase Alfa (Atc Code According To Who: R05Cb13)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Dornase Alfa (Atc Code According To Who: R05Cb13)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Dornase Alfa (Atc Code According To Who: R05Cb13)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Dornase Alfa (Atc Code According To Who: R05Cb13)
Tenders by Country